Welcome to Cross-Canada Paediatric - Respiratory Residency Rounds
Page 16 / Case 10.03


1. A P Boon et al : 10 years review of invasive aspergillosis detected at narcolepsy, J clin pathol 1991, 44, 452-454

2. A.Haugaard et al: early chest radiography and CT in the diagnosis ,management and out come of invasive pulmonary aspergillosis acta radiologica 43, (2002) 292-298

3. A.H.Groll et al: five -years-survey of invasive aspergillosis in a pediatric cancer centre. Epidemiology, management and long term survival, mycosis 42, 431-442 (1999)

4. Andrea Hayes-Jordan et al: open lung biopsy in pediatric bone marrow transplant patients; Journal of pediatric surgery, vol 37, no 3 (March) 2002: pp 446-452

5. Caillot D: improved management of IPA in neutropenic patients using early thoracic CT and surgery, J of clinical oncology, 15:139, 1997

6. Christopher T.Salerno et al: surgical therapy for pulmonary aspergillosis in immunocompromised patients Ann Thorac surg 1998, 65, 1415-9

7. Clare Savage et al: hemoptysis secondary to pulmonary pseudoaneurysm 30 years after a gunshot wound, Ann thorac surg 2001, 71, 1021-3

8. David W. Denning et al: efficacy and safety of voriconazole in the treatment of acute invasive asergillosis, clinical infectious diseases 2002, 34, 563-571

9. Dominique Gossot et al: full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis, Ann Thorac Surg 2002,73, 240-4

10. Dieter Buchheidt et al: clinical evaluation of PCR assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

11. Eddy Jean-Baptiste : clinical assessment and management of massive haemoptysis, crit. Care med 2000, vol 28, p.1642-47

12. Erik J .Dubach et al :burden of aspergillosis -related hospitalizations in the united states clinical infectious disease 2000; 1524-8

13. Frank Reichenberger et al: lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematological diseases Ann J respir crit care med vol 158, pp885-890,1998

14. F Reichenberger et al: diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis; bone marrow transplantation (1999) 24 .1195-1199

15. G.F.Behre et al: Aerosol amphotercin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients Ann hematol (1995), 71, 287-291

16. G.Todeschini C .Murari et al: invasive aspergillosis in neutropnic patients : rapid neutrophil recovery is a risk factor for sever pulmonary complication European Journal of clinical investigation (1999) 29, 453-457

17. Gorelik et al: fatal hemoptysis induced by invasive pulmonary aspergillosis in patients with acute leukemia buring bone marrow and clinical remission: reports of two cases and review of the literature, 2000, the British infectionj society

18. Hans J Dornbusch et al: treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorder using ambisone and GCSF pediatric hematology and oncology 12(6) 577-586,1995

19. Hyung Jin Won et al: invasive pulmonary aspergillosis : prediction at thin - section CT patients with Neutropenia - A prospective study, radiology 1998; 208:777-782

20. Issam Raad et al : PCR on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients, cancer, February 15, 2002, vol 94/number 4

21. James M.Habicht at al: invasive fungal infection in hematologic patients: is resection effective? the hematology journal 2001, 2, 250-256

22. J. Cap et al: fluconazole in children, chemotherapy 1993, 39, 438-442

23. Jean-Francois Regnard et al: A series of 89 surgical cases Ann Thorac Surg 2000, 69, 898-903

24. J.L.Harousseau et al: Itraconazole oral solution for treatment for primary prophylaxis for fungal infection inpatients with hematological malignancy and profound neutropenia Antimicrobial agents and chemotherapy, July, 2000,p.1887-1893

25. J.J.W.M.Janssen et al: out come of ICU treatment in invasive aspergillosis ;intensive care med (1996) 222, 1325-1322

26. John R Perfect at al: voriconazole treatment for less-common,emerging,or refractory fungal infections, clinical inf. Diseases 2003, 36, 1122-31

27. Livio Panago et al : the role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological diseases, Ann med 29 535-540.

28. Masahirno Kami et al: use of real -time PCR on blood samples for diagnosis of invasive aspergillosis clinical infectious diseases 2001,33:1504-1512

29. Mashiro Kami et al: computed tomography of the chest, latex agglutination test and plasma 1-3)_-D-glucan assay in early diagnosis of invasive aspergillosis, Haematologica 2000; 85:745-752

30. Marcio Nucci et al: double, blinded ,randomized placebo-controlled trial of itraconazole capsules as anti fungal prophylaxis for neutropenic patients, clinical infectious diseases 2000, 30, 300-5

31. Mary H. White et al: Amphotercin B colloidal dispersion VS amphotercin B as therapy for invasive aspergillosis clinical infectious diseases 1997; 24, 635-642

32. M. Von.Eiff et al pulmonary aspergillosis: early diagnosis improve survival; respiration 1995, 62, 341-347

33. M. Cornet et al : epidemiology of invasive aspergillosis in France J of hospital infection ,2002, 51, 288-296

34. M E Ellis et al : progressive chronic pulmonary aspergillosis, J of the royal society of medicine vol 85, December 1992 p.763-4

35. M. Karim et al : chronic invasive aspergillosis in apparently immunocomptent hosts, clin infect dis 1997, 24, 723-33

36. Min Joo Kim et al: crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors Journal of computer assisted tomography 25:305-310.

37. M E Jones et al PCR-ELISA for the early diagnosis of invasive pulmonary asergillus infection in neutropenic patients; J clin pathol 1998; 51, 652-656

38. O.Rinden et al: efficacy of amphotercin B encapsulated in liposome (ambisone) in the treatment of invasive fungal infections in the treatment of invasive fungal infection in immunocompromised patients Journal of antimicrobial chemotherapy (1991) 28, suppl.B.73-82

39. O.Rigden and J.Tollemar: liposomal amphotercin B ( ambisone) treatment of invasive fungal infection in immunocompromised children , mycosis ,36,187-192 (1993)

40. Patterson, Thomas F: disease spectrum, treatment practice and outcome, medicine (Baltimore), vol79, July, 2000. 250-260

41. Paul Pianosi and H Al-sadoon: hemoptysis in children, pediatric in review vol 17, no.10, oct 96.

42. Raleigh Bowden et al: A double blind, controlled trial of Amphotercin B colloidal dispersion versus Amphotercin B for treatment of invasive aspergillosis in immunocompromised patients

43. Raed A Dweik et al: role of bronchoscopy in massive haemoptysis, clinics in chest medicine, vol 20, number 1, march 1999.

44. Raoul Herbrecht et al : voriconazole versus amphotercin B for primary treatment of invasive aspergillosis N Eng J Med vol 347, no.6 (august 8 ) 2002

45. Stanley C. Deresinski and David A Stevens: caspofungin clinical infec. Diseases ,2003, 1445-57

46. Seema Abbasi et al, apergillosis in children with cancer : a 34 years experience, clinical infectious diseases 1999; 29: 1210-9.

47. Sharon Walmsley et al : invasive aspergillosis in a pediatric hospital, J of infect dis, 1993, 12, 673-82

48. S.Bretagne et al :serum aspergillus galactomannan antigen testing by sandwish ELISA: practical use in neutropenic patients Journal of infection (1997), 35, 7-15

49. Swu-Jane Lin et al: aspergillosis case fatality rate, clinic infect dis 2001, 32, 358-66

50. Timothy B. Allff et al: refractory aspergillus pneumonia in patients with acute leukemia, cancer February 15, 2003 vol 97, number 4

51. Thomas J. Walsh et al :voriconazole in the treatment of aspergillosis ,pediatric infectious diseases journal .2002, 21:240-8

52. T.J. Marchall et al : the role of radiology in the investigations and managements of patients with hemoptysis, 1996, the royal college of radiologist, clinical radiology, 51,391-400

53. V. Ribrag et al : prognostic factors for invasive pulmonary aspergillosis in leukemic patients, J of leukemia and lymphoma vol. 10, pp.317-321 12 15

THANK YOU FOR JOINING US FOR THE CROSS-CANADA PAEDIATRIC RESPIRATORY ROUNDS. HOPE TO SEE YOU NEXT TIME.Thank you to AstraZeneca for their support of this program and website.

BACK TO HOME 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Archives / Contact us